Author

A. Bensaid

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:differential expression· 1 Organism:mouse· 1 Organism:multiple species· 1

Frequent Co-Authors

J. Rodon· 3 shared J. Segales· 3 shared J. Vergara-Alert· 3 shared M. Ballester· 2 shared M. Perez· 2 shared N. Te· 2 shared A. Valencia· 1 shared B. Clotet· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

J. Rodon

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

High-throughput quantification of camelid cytokine mRNA expression in PBMCs by microfluidic qPCR technology

J. Rodon, N. Te, M. Ballester, J. Segales, J. Vergara-Alert, A. Bensaid

The paper develops RT-qPCR assays to quantify immune response genes in camelid PBMCs and identifies species-specific cytokine responses to stimulations.

bioRxiv · Jan 15, 2023 · PreprintImmunology

Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in hamsters

M. Brustolin, J. Rodon, M. L. Rodriguez de la Concepcion, C. Avila-Nieto, G. Cantero, M. Perez, T. Nigeer, M. Noguera-Julian, V. Guallar, A. Valencia, N. Roca, N. Izquierdo-Useros, J. Blanco, B. Clotet, A. Bensaid, , J. Segales

This study shows that hamsters infected with SARS-CoV-2 are not fully protected against reinfection with both original and variant isolates, but experience reduced lung disease severity upon re-exposure.

bioRxiv · Jan 7, 2021 · PreprintPathology

Type I and III IFNs produced by the nasal epithelia and dimmed inflammation are key features of alpacas resolving MERS-CoV infection

N. Te, J. Rodon, M. Ballester, M. Perez, L. Pailler-Garcia, J. Segales, J. Vergara-Alert, A. Bensaid

This study identifies type I and III IFNs in nasal mucosa and anti-inflammatory responses as key to alpacas resolving MERS-CoV infection without severe symptoms.

bioRxiv · Nov 23, 2020Immunology